Supercharge Your Innovation With Domain-Expert AI Agents!

Applications of simvastatin in preparation of hepatitis B virus inhibition drugs

A technology of simvastatin and hepatitis B virus, applied in the field of western medicine, can solve the problems such as the lack of simvastatin, and achieve the effect of strong anti-hepatitis B virus activity and inhibition of replication

Inactive Publication Date: 2017-07-28
THE FIRST AFFILIATED HOSPITAL OF MEDICAL COLLEGE OF XIAN JIAOTONG UNIV
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no relevant research report on simvastatin targeting MCM7 to inhibit cell proliferation, so it is of positive significance and research value to clarify the mechanism of simvastatin in HBV infection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of simvastatin in preparation of hepatitis B virus inhibition drugs
  • Applications of simvastatin in preparation of hepatitis B virus inhibition drugs
  • Applications of simvastatin in preparation of hepatitis B virus inhibition drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] MTT assay to detect cell proliferation ability

[0036] Take HepG2.2.15 liver cancer cells in the logarithmic growth phase, digest the cells with a digestive solution containing 0.25% trypsin (Trypsin) + 0.02% EDTA, centrifuge to discard the supernatant, blow and beat with complete medium, and then use a cell counting board to count. 3×104 / well were inoculated in 96-well culture plates. After 24 hours of incubation, the cells were treated with different concentrations of simvastatin (as shown in Table 1), and 5 auxiliary wells were set for each concentration. After 1, 2, 3, 4, 5, 6, and 7 days of drug action, add 20 μl of 500 μg·ml-1 MTT, incubate at 37°C for 4 hours, discard the culture medium, then add 150 μl of DMSO to each well, shake for 15 minutes and mix well. The absorbance (A) value of each well at 570 nm was detected with a microplate reader. Subtract the background A value (cell-free medium plus MTT reagent) from the A value of each test well; calculate the...

Embodiment 2

[0041] Cell counting assay to detect cell proliferation

[0042] Take HepG2.2.15 liver cancer cells in the logarithmic growth phase, digest the cells with a digestive solution containing 0.25% trypsin (Trypsin) + 0.02% EDTA, centrifuge to discard the supernatant, blow and beat with complete medium, and then use a cell counting board to count. 3×104 / well were inoculated in 96-well culture plates. After 24 hours of incubation, the cells were treated with different concentrations of simvastatin (as shown in Table 1), and 5 auxiliary wells were set for each concentration. After 1, 2, 3, 4, 5, 6, and 7 days of drug action, the cells were digested with 0.25% trypsin, and fully pipetted to prepare a single-cell suspension. The counting plate and coverslip were cleaned with 95% ethanol and dried in air. Cover the coverslip on the counting plate, mix the cell suspension well, suck up the cells with a pipette, and gently drop about 10 μl of the cell suspension from the edge of the cou...

Embodiment 3

[0044] Western-blot analysis

[0045] 1) Preparation of protein samples: Remove the culture medium from the cells that have been cultured and treated accordingly, rinse with pre-cooled (4°C) PBS 3 times, try to blot the remaining PBS as dry as possible, then add pre-cooled protein lysate, Lyse on ice for 30 min. Thereafter, the cells were collected with a cell scraper, centrifuged at 12000 rpm for 2 min at 4°C, and the supernatant was taken. A small amount of the supernatant was taken for protein quantification, and the rest was added to Loading Buffer, boiled at 104°C for 30 minutes, and then stored at -20°C for later use.

[0046] 2) Preparation of electrophoresis gel: prepare 5% stacking gel and 10% separating gel according to Table 2. The amount of total protein loaded was 50 μg, and electrophoresis was performed at 60V. After the leading edge of the sample entered the separation gel, the voltage was adjusted to 100V, and electrophoresis was continued for about 1.5 hours...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention belongs to the technical field of medicine, and particularly relates to applications of simvastatin in preparation of hepatitis B virus inhibition drugs, more particularly applications of simvastatin in preparation of drugs using MCM7 as a target, more especially applications of simvastatin in preparation of hepatitis B virus inhibition drugs using MCM7 as a target. According to the present invention, simvastatin inhibits the HBV replication in HepG2.2.15 cells and blocks the cell cycle progression by inhibiting the MCM7 expression level in the cells, has strong anti-hepatitis B virus activity, and provides the new effective method for the clinical preparation of hepatitis B virus inhibition drugs.

Description

technical field [0001] The invention relates to the use of medicines, in particular to the application of simvastatin in the preparation of medicines for inhibiting hepatitis B virus, and belongs to the field of western medicines. Background technique [0002] Hepatitis B virus (HBV) infects about 400 million people and is the most common chronic infectious disease worldwide. It is the main cause of primary hepatocellular carcinoma (HCC), and about 1 million people die from HBV infection every year liver failure, cirrhosis and liver cancer. At present, interferon and nucleoside analogs are the main treatments for HBV infection. The long-term effective rate of interferon treatment is only about 30%, and there are many toxic and side effects; although nucleoside analogs such as lamivudine have strong antiviral ability However, the rapid rebound of viral replication and the emergence of drug-resistant virus strains after drug withdrawal make the implementation of clinical anti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/366A61P31/20
CPCA61K31/366
Inventor 刘培军安红丽王博李娟李萍萍刘洁苗裔梁哲勇曹菲
Owner THE FIRST AFFILIATED HOSPITAL OF MEDICAL COLLEGE OF XIAN JIAOTONG UNIV
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More